Board Members

Executive board

Martin Jechlinger

Martin Jechlinger

Martin Jechlinger completed his studies in biochemistry and neurobiology in 1997 at the University of Vienna. He then followed his interest in cancer biology and joined the group of Hartmut Beug at the Institute of Molecular Pathology (IMP) in Vienna as a PhD student. In Hartmut’s laboratory he studied Epithelial to Mesenchymal Transition (EMT) in the context of Cancer-Metastasis and obtained his PhD in 2002. He then went to New York to work in the laboratory of Harold Varmus at MSKCC as a Postdoctoral Research Fellow. He continued to explore breast cancer biology and the mechanisms of oncogene dependence in three-dimensional culture systems of primary mouse mammary cells. In 2010 he moved to Rome to run his laboratory at the EMBL Mouse Biology Unit. Since 2015 he is group leader at the "Cell Biology and Biophysics Unit" at the EMBL Heidelberg.

Margrit Beug

Margrit Beug

Margrit Beug studied Biology and Geography in Freiburg, where she met Hartmut. She has taught biology and geography in Sindelfingen, Schriesheim and Ladenburg. In Vienna she was active in educational projects for the World Wildlife Fund-Austria.

Board of Trustees and Scientific Advisory Board

Anton Bauer

Anton Bauer

After finishing his studies in biochemistry and immunology at the University of Vienna in 1993, Anton Bauer joined the group of Hartmut Beug at the Research Institute of Molecular Pathology in Vienna to analyse the mechanism of oncogene co-operation for tumor growth, mimicking the mode of action of hormone receptors during proliferation in hematopoietic progenitor cells. He obtaining his PhD in 1998 and moved to the German Cancer Research Center in Heidelberg. There he focused his studies on the influence of glucocorticoid receptor for the maturation and function of cells of the immune system. In 2001 he returned to Austria, turning from basic research towards translational sciences in small biotech companies, where he worked on Alzheimer’s disease at Axon Neurosciences and on developing a next generation antibodies platform at the start-up company f-star, and establishing the endogenous human antibody platform at Intercell/Valneva Austria in Vienna. Currently he is co-managing a new endeavor in Vienna, "The Antibody Lab". Anton Bauer holds a PhD degree in biochemistry from the University of Vienna, and an MBA from both the University of Minnesota and the University of Business and Economics in Vienna.

Jacques Ghysdael

Jacques Ghysdael

Jacques Ghysdael obtained his PhD degree in 1979 at the Department of Molecular Biology of the Université Libre de Bruxelles, Brussels, Belgium. From 1980-1982 he pursued studies on the genetic structure of retroviruses and viral oncogenes at the Department of Microbiology, University of Southern California, Los Angeles, USA. In 1983, he joined the Institut Pasteur in Lille, France, to investigate the function of several viral oncogenes and their proto-oncogenic versions. During those years, he began a long and friendly collaboration with Hartmut Beug, in particular on various aspects of the function of c-ErbA/v-ErbA and ETS family members. This fruitfull collaboration went on after his move in 1990 to the Institut Curie, Paris, France. Ongoing studies involve the dissection of pro-oncogenic pathways involved in leukemia and of calcineurin and NFAT factors in breast cancer metastasis.

Marieke von Lindern

Marieke von Lindern

Marieke von Lindern obtained her PhD degree in 1992 in the Dept. Cell Biology and Genetics at the Erasmus University, Rotterdam, The Netherlands. From 1992 to 1995 she worked at the IMP in Vienna, Austria, being trained by Hartmut Beug in the cell biology of erythropoiesis. She returned to The Netherlands to start her own research group at the Department of Hematology at the Erasmus Medical Center. She focused on molecular mechanisms in erythropoiesis and maintained a close cooperation with Hartmut Beug, as evidenced by many common research publications. In 2010 she moved to the Research Center of Sanquin Blood Supply in Amsterdam, where she is head of the Department of Hematopoiesis.